Stay updated with breaking news from Executive Albert Bourla. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
(Reuters) - Pfizer Inc will make all of its patented medicines including COVID-19 treatment Paxlovid and big-selling breast cancer drug Ibrance available at a not-for-profit price to 45 of the world's poorest countries, the drugmaker said on Wednesday.
'We’ve had big crises in the past but coming from so many different dimensions this may be quite unique,' Standard Chartered Plc Chairman Jose Vinals said.
Pfizer Inc (PFE.N) will make all of its patented medicines including Covid-19 treatment Paxlovid and big-selling breast cancer drug Ibrance available at a not-for-profit price to 45 of the world's poorest countries, the drugmaker said on Wednesday.
As Paxlovid has become more widely used, some patients have reported that COVID-19 symptoms recurred after completing treatment.
More than 2.8 million courses of Pfizer Inc’s Covid-19 oral antiviral treatment Paxlovid have been made available at pharmacies around the United States, with the Biden administration working to improve access to the drug. As Paxlovid has become more widely used, some patients have reported that Covid-19 symptoms recurred after completing treatment and experiencing improvement. Here is the latest information...